In Vitro Toxicology Market

 
   Single User - $4,500
   Site License (one location, 10 users) - $6,750
   Corporate License - $9,000



Loading...
Published Jul 19, 2018 | 408 Pages | Pub ID: KLI15733879

In Vitro Toxicology

The in vitro toxicity testing markets include methods and technologies used for toxicity testing of pharmaceuticals, cosmetics, chemicals and food ingredients based on biochemical, cellular and tissue-based assays and platforms. Major stake holders of this market include technology platform developers, reagents and labware suppliers, service providers and end-use industry segments that need to comply with regulatory safety data requirements. In Vitro Toxicology examines global in vitro toxicity testing markets, regional market segments and industry segments, including the following market data:
  • Market Shares of Regional Market Segments of the In Vitro Toxicity Testing Markets, 2018 (North America, Europe, Asia Pacific, ROW)
  • Market Size and Growth Trends of Various Toxicity Endpoint Segments of the Global In Vitro Toxicity Testing Markets (2018-2023) (ADME-Tox; Cytotoxicity; Genotoxicity; Ocular Toxicity; Skin Irritation, Corrosion, and Sensitization; Dermal Toxicity; Carcinogenicity; Phototoxicity; Neurotoxicity; Organ Toxicity; Other Endpoints and Tests)
  • Market Shares of Industry Segments of the Global In Vitro Toxicity Testing Markets, 2018 (Pharmaceutical, Cosmetics, Chemicals, Others [Food, Medical Devices, etc.])
  • Global In Vitro Toxicity Testing Market, by Toxicity Endpoints and Tests (2018-2023) (ADME-Tox; Skin Irritation, Corrosion, and Sensitization; Genotoxicity; Cytotoxicity; Ocular Toxicity; Organ Toxicity; Phototoxicity; Dermal Toxicity; Carcinogenicity; Neurotoxicity; Other Toxicity Endpoints & Tests; Total)
  • Markets for In Vitro ADME-Tox Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Skin Irritation, Corrosion and Sensitization Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Genotoxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Cytotoxicity Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Ocular Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Organ Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Phototoxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Dermal Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Carcinogenicity Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Neurotoxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Global Demand for Other Toxicity Endpoints and Tests within In Vitro Toxicity Testing Markets, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
The Market by Technology

A major factor that has enabled the growth of the in vitro toxicity testing market is the advancement of various technologies such as cell culture technologies, high throughput technologies, cellular imaging technologies, and toxicogenomics. The advancement in 3D cell culture technologies, which are replacing 2D cell culture technologies, offer an opportunity to develop complex models that are better able to mimic in vivo systems.

The report presents market sizing of these technology segments and assesses their future growth trends. Regional breakouts of these technology segments and overall market growth trends are among the data points presented:
  • Global In Vitro Toxicity Testing Market, by Technology (2018-2023) (Cell Culture Technologies, High Throughput Screening, Cellular Imaging Technologies, Toxicogenomics, Total)
  • Markets for Cell Culture Technologies for In Vitro Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for High Throughput Technologies for In Vitro Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for Cellular Imaging Technologies for In Vitro Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for Toxicogenomics Technologies for In Vitro Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
The Market by Industry

Key end-use industry segments for in vitro toxicity testing markets include the pharmaceutical, chemicals and cosmetics industries. The report analyses the internal dynamics of each of these segments with respect to individual regional markets and assess their growth trends, including:
  • Markets for In Vitro Toxicity Testing in the Pharmaceutical Industry, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Toxicity Testing in the Cosmetics Industry, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Toxicity Testing in the Chemical Industry, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • In Vitro Toxicity Testing Markets in Other Industry Segments, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
The Market by Method

Reducing animal-based toxicity testing is becoming a possibility as public and private funding investments focus on the development of robust in vitro platforms. Cellular and organotypic models and assays are accounting for a large share of the in vitro toxicity market as their ability to predict toxic effects in vivo is improving with technology advancements. Emerging market segments based on various methods for in vitro toxicity testing can be broadly classified into biochemical assays, cell-based assays and ex vivo systems. Significant innovation is happening in the 3D cell culture-based method segment, which can influence the market landscape of in vitro toxicity testing. The report includes the following method-related in vitro toxicity testing market data:
  • Global In Vitro Toxicity Testing Market, by Method (2018-2023) (Biochemical assays, 2D Cell-based assays, 3D cell culture assays and Ex vivo systems, Total)
  • Markets for Biochemical Assays in In Vitro Toxicity Testing Markets, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for 2D Cell-based Assays within In Vitro Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for 3D Cell Culture Assays and Ex Vivo Systems within In Vitro Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
The Market by Products and Services

The products and services segments within in vitro toxicity testing markets can be broadly segmented into various assays, services and reagents and labware. In Vitro Toxicology analyses the growth trends within each of these segments and estimates their market sizing in global and regional markets:
  • Global In Vitro Toxicity Testing Market, by Products and Services (2018-2023) (Assays, Services, Reagents & Labware, Total)
  • Markets for Various Assays for In Vitro Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for Reagents and Labware for In Vitro Toxicity Testing, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Markets for In Vitro Toxicity Testing Services, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
The Market by Region

The report provides a close look into the leading regions in in vitro toxicity testing markets, presenting market sizing and forecasts of the global in vitro toxicity market by country/region:
  • Global In Vitro Toxicity Testing Market, by Region (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • Europe
  • In Vitro Toxicity Testing Market in Europe, by Products and Services (2018-2023) (North America, Europe, Asia Pacific, ROW, Total)
  • In Vitro Toxicity Testing Markets in Europe: By Toxicity Endpoints (2018-2023) (ADME-Tox; Skin Irritation, Corrosion, and Sensitization; Genotoxicity; Cytotoxicity; Ocular Toxicity; Organ Toxicity; Phototoxicity; Dermal Toxicity; Carcinogenicity; Neurotoxicity; Other Toxicity Endpoints & Tests; Total)
  • In Vitro Toxicity Testing Markets in Europe: By Technology (2018-2023) (Cell Culture Technologies, High Throughput Screening, Cellular Imaging Technologies, Toxicogenomics, Total)
  • In Vitro Toxicity Testing Markets in Europe: By Method (2018-2023) (Biochemical assays, 2D Cell-based assays, 3D cell culture assays and Ex vivo systems, Total)
  • In Vitro Toxicity Testing Markets in Europe: By Industry (2018-2023) (Pharmaceutical, Cosmetics, Chemicals, Others [Food, Medical Devices, etc.], Total)
  • North America
  • In Vitro Toxicity Testing Markets in North America: By Products and Services (2018-2023) (Assays, Services, Reagents & Labware, Total)
  • In Vitro Toxicity Testing Markets in North America: By Toxicity Endpoints (2018-2023) (ADME-Tox; Skin Irritation, Corrosion, and Sensitization; Genotoxicity; Cytotoxicity; Ocular Toxicity; Organ Toxicity; Phototoxicity; Dermal Toxicity; Carcinogenicity; Neurotoxicity; Other Toxicity Endpoints & Tests; Total)
  • In Vitro Toxicity Testing Markets in North America: By Technology (2018-2023) (Cell Culture Technologies, High Throughput Screening, Cellular Imaging Technologies, Toxicogenomics, Total)
  • In Vitro Toxicity Testing Markets in North America: By Method (2018-2023) (Biochemical assays, 2D Cell-based assays, 3D cell culture assays and Ex vivosystems, Total)
  • In Vitro Toxicity Testing Markets in North America: By Industry (2018-2023) (Pharmaceutical, Cosmetics, Chemicals, Others [Food, Medical Devices, etc], Total)
  • APAC
  • In Vitro Toxicity Testing Markets in APAC: By Products and Services (2018-2023) (Assays, Services, Reagents & Labware, Total)
  • In Vitro Toxicity Testing Markets in APAC: By Toxicity Endpoints (2018-2023) (ADME-Tox; Skin Irritation, Corrosion, and Sensitization; Genotoxicity; Cytotoxicity; Ocular Toxicity; Organ Toxicity; Phototoxicity; Dermal Toxicity; Carcinogenicity; Neurotoxicity; Other Toxicity Endpoints & Tests; Total)
  • In Vitro Toxicity Testing Markets in APAC: By Technology (2018-2023) (Cell Culture Technologies, High Throughput Screening, Cellular Imaging Technologies, Toxicogenomics, Total)
  • In Vitro Toxicity Testing Markets in APAC: By Method (2018-2023) (Biochemical assays, 2D Cell-based assays, 3D cell culture assays and Ex vivo systems, Total)
  • In Vitro Toxicity Testing Markets in APAC: By Industry (2018-2023) (Pharmaceutical, Cosmetics, Chemicals, Others [Food, Medical Devices, etc], Total)
Competitive LandscapeIn Vitro Toxicology profiles many leading and niche players in the market, including:
  • BioIVT Group
  • Cell Biolabs, Inc.
  • Charles River Laboratories International, Inc.
  • CiToxLAB Group
  • Covance Inc.
  • Creative Bioarray
  • Cyprotex Plc (currently under Evotec AG)
  • Enzo Life Sciences, Inc. (subsidiary of Enzo Biochem, Inc.)
  • Eurofins Scientific S.E.
  • Gentronix Limited
  • HemoGenix, Inc.
  • MatTek Corporation
  • MB Research Laboratories
  • MIMETAS B.V.
  • Organovo Holdings, Inc.
  • Thermo Fisher Scientific Inc.
  • TissUse GmbH
  • Xenometrix AG
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.